Study design and participants
allergic, chronic diseases
WEST, SECONDARY, CHRONIC DISEASES
The present study is a secondary analysis from the “Mommy’s Food” study (NCT02610959), which was conducted in Bergen, Norway (2016–2018). The study was a randomized controlled trial, where a total of 137 pregnant females were assigned to either receive Atlantic cod (Flowchart of the study population. Abbreviations: GW18, gestation week 18; GW36, gestation week 36; PP, postpartum.The inclusion criteria included pregnant females with primiparous singleton pregnancies in GW ≤19 who spoke and/or understood Norwegian writing. Given the intervention with Atlantic cod, females who were allergic to fish or had chronic diseases affecting iodine status were excluded. All study participants provided written informed consent. The trial was conducted in accordance with the Declaration of Helsinki and was approved by the Regional Ethical Committee for Medical and Health Research Ethics West (2015/897).